Sicherheit für Arzneimittel und Medizinprodukte
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) (bfarm.de) scores 68 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Government brands, in the 17th percentile of 12438 Healthcare brands.
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is Germany's independent federal higher authority responsible for the approval, monitoring, and safety oversight of medicinal products and medical devices. Established in 1994 and headquartered in Bonn, it operates within the portfolio of the Federal Ministry of Health. BfArM provides scientifically grounded evaluations to protect patient safety, serving pharmaceutical companies, medical device manufacturers, healthcare professionals, patients, and the general public with information on drug and device safety.
| Brand Name | BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) |
|---|---|
| Domain | bfarm.de |
| Industry | Healthcare, Government |
| Founded | 1994 |
| Headquarters | Bonn |
| Parent Company / Owner | Federal Ministry of Health of Germany |
| Main Competitors | European Medicines Agency (EMA), Paul-Ehrlich-Institut (74/100), U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Swissmedic (67/100), Agence nationale de sécurité du médicament (ANSM) |
Moz Domain Authority 63/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #33,170 on the Tranco list of most-visited sites - strong traffic reinforces the brand's prominence to AI models.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) ist eine selbstständige Bundesoberbehörde im Geschäftsbereich des Bundesministeriums für Gesundheit." (Meta description: 17 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is DE-only, limiting citation in English-language AI answers.
Detected tech stack: Apache.
Social footprint: verified profiles on LinkedIn, Instagram, GitHub; no detected presence on X (Twitter), Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)?", Claude could identify the brand as of September 2026. BfArM is the German Federal Institute for Drugs and Medical Devices, a federal authority under the Federal Ministry of Health that authorizes and monitors medicines and medical devices in Germany. It handles drug approval, pharmacovigilance, and regulation of narcotics and medica Best known for Being Germany's national regulatory authority for drug and medical device approval.
When asked "Best brands similar to BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)?", Claude would recommend BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) as of September 2026. If someone asks about drug regulatory bodies or agencies similar to EMA or FDA in Europe, BfArM is a key national authority worth mentioning.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)'s main competitors in Healthcare: Paul-Ehrlich-Institut (74/100), U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Swissmedic (67/100).
Sources: Brand Analyzer scan
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is an independent German higher federal authority operating under the Federal Ministry of Health. Founded in 1994 and based in Bonn, it is responsible for supervising the safety and efficacy of medicinal products and medical devices in Germany.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 25, trust 34, recommendation 40). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) was founded in 1994. BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is headquartered in Bonn. BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) operates in the Healthcare category.
Sources: Wikidata
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) scores 40/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
BfArM provides regulatory services including the evaluation and approval of medicinal products, oversight and safety monitoring of medical devices, and dissemination of safety-related information to healthcare stakeholders and the public, all in the interest of patient protection.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
As an independent federal higher authority under Germany's Federal Ministry of Health, BfArM is structured to provide impartial, scientifically grounded oversight of medicinal products and medical devices, which supports its role as a trusted regulatory body in the German healthcare system.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
BfArM is known for its role as Germany's central federal authority for the authorization, surveillance, and safety monitoring of drugs and medical devices, providing independent scientific assessments within the German healthcare regulatory system.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) is owned by or part of Federal Ministry of Health of Germany. BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) operates in the Healthcare category.
Sources: Wikidata
BfArM's services are used by pharmaceutical companies and medical device manufacturers seeking approval and oversight, medical professionals seeking safety guidance, and patients and the general public seeking information on medicinal product and device safety.
Sources: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) official site
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (40/100) and its weakest is visibility (25/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #33,170 (Tranco) and a Moz Domain Authority of 63/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte): Better Health Channel (68/100), BEKhealth (68/100), Bioengineering (68/100), Bio-Rad Laboratories (68/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.